Shares of Synairgen plc (LON:SNG – Get Free Report) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 5.02 ($0.07) and traded as low as GBX 4.30 ($0.06). Synairgen shares last traded at GBX 4.62 ($0.06), with a volume of 63,603 shares changing hands.
Synairgen Trading Down 11.8 %
The company has a market capitalization of £8.88 million, a P/E ratio of -153.83 and a beta of -2.23. The company has a debt-to-equity ratio of 0.09, a current ratio of 6.77 and a quick ratio of 6.35. The firm has a fifty day moving average price of GBX 3.93 and a 200-day moving average price of GBX 5.02.
About Synairgen
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease.
Featured Articles
- Five stocks we like better than Synairgen
- Using the MarketBeat Stock Split Calculator
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- The 3 Best Blue-Chip Stocks to Buy Now
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- The How and Why of Investing in Gold Stocks
- Tesla Stock: Buy the Dips, Sell the Rips
Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.